Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,197-2,208 of 4,306
Other study type icon
CompletedNCT02187835

Decreased EEG Complexity in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Istanbul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Türkiye
Sponsor
Uskudar University
Condition
Schizophrenia
Other study type icon
CompletedNCT00501163

Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

In St Louis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 10 Years to 55 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Schizophrenia
Other study type icon
CompletedNCT00573300

Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 65 Years
Countries
United States
Sponsor
North Suffolk Mental Health Association
Condition
Schizophrenia
Other study type icon
CompletedNCT01035996

Dopamine Function and Reward Processing In Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 50 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Schizophrenia
Drug study icon
CompletedNCT00580125

Safety study of Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in schizophrenia

This study is completed in the United States, in India, in Russia, .... It is testing Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States, India, Russia, ...
Sponsor
Pfizer
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.